Fluigent is collaborating with Aloïse MABONDZO, Nathan Métivet, and their research team at the CEA to develop in vitro brain organoid models for Traumatic Brain Injury, Hypoxic-Ischemic Encephalopathy, and neurodevelopmental disorders using the automated platform OmiTM.

Fluigent develops, manufactures and commercializes innovative fluid handling solutions for a variety of rapidly growing applications where fluid control is critical. We have delivered microfluidic solutions to hundreds of customers worldwide since 2006. We offer to our customers a full range of engineering services and technical assistance to design and optimize their set-ups. Our solutions are modularized, enabling our customers to save precious time with cumbersome engineering fluidic developments (such as re-designing and re-developing electronic and software interfaces for each new set-up). Quality is at the center of all our activities. Our Customers can benefit from our ISO-9001 certified processes. Certification renewal took place in early 2025 for an additional 3 years. Fluigent’s patented FASTAB technology is unique. We have proprietary pneumatic and electronic design, enabling us to finely tailor the product design to each customer need. Today, Fluigent is the first Company to introduce a full pressure and flow-rate solution designed for coupled multi-channel configurations. We aim at providing our customers with the most advanced microfluidic tools, and help them being successful in all their microfluidic applications.